Listen Now
Topics Covered
- Overview of Diffuse Large B-Cell Lymphoma, in the Context of COVID-19
- Staging and Grading
- Current Standard of Care
- Treatment Options for Resistant Disease
- Emerging Treatment Approaches
- The Role of Clinical Trials
- How Research Contributes to Treatment Choices
- Tips to Manage Side Effects
- The Role of Telehealth/Telemedicine Appointments in Reducing Your Exposure to COVID-19
- Guidelines to Prepare for Telehealth/Telemedicine Appointments
- Key Questions to Ask Your Health Care Team
- Quality-of-Life Concerns
- Questions for Our Panel of Experts
Our Panel of Experts

David J. Straus, MD
Attending Physician, Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Professor of Clinical Medicine, Weill Cornell Medical College

Sarah C. Rutherford, MD
John P. Leonard, MD/Gwirtzman Family Research Scholar in Lymphoma, Assistant Professor of Medicine, Weill Cornell Medical College, Cornell University

Adolfo Enrique Diaz, MD, MSc
Assistant Professor, Department of Medicine, Division of Hematology-Oncology, Mays Cancer Center, UT Health San Antonio MD Anderson Cancer Center

Catherine S M Diefenbach, MD
Associate Professor of Medicine, Translational Director Hematology/Director Clinical Lymphoma, Perlmutter Cancer Center, An NCI-designated Comprehensive Cancer Center, NYU Langone Health

Carolyn Messner, DSW, BCD, FAPOS, FAOSW
Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on November 18, 2020.